Streetbeat News

Analyst Ratings

ON

The analysis of ON Semiconductor (NASDAQ:ON) compared to its competitors in the Semiconductors & Semiconductor Equipment industry reveals potential undervaluation based on its PE, PB, and PS ratios. Despite a high ROE indicating strong profitability, concerns arise from its low EBITDA, gross profit, and negative revenue growth. The company's lower debt-to-equity ratio suggests a stronger financial position relative to its top 4 peers.

Portfolio Pulse from Benzinga Insights

February 22, 2024 | 4:00 pm

RUN

BMO Capital analyst Ameet Thakkar has maintained a Market Perform rating on Sunrun (NASDAQ:RUN) and increased the price target from $18 to $20.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 4:00 pm

HRMY

Analyst ratings for Harmony Biosciences (NASDAQ:HRMY) show mixed sentiments with a recent shift towards bullishness. The average 12-month price target has increased by 31.9% to $38.25. Analysts from Needham, Mizuho, Goldman Sachs, and B of A Securities have updated their ratings and price targets, reflecting changes in market conditions and company performance. Harmony Biosciences, a commercial-stage pharmaceutical company, has shown remarkable financial health with significant revenue growth, high net margin, and effective debt management.

Portfolio Pulse from Benzinga Insights

February 22, 2024 | 4:00 pm

WING

BMO Capital analyst Andrew Strelzik has maintained a 'Market Perform' rating on Wingstop (NASDAQ:WING) and raised the price target from $235 to $275.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 3:57 pm

CSGP

BMO Capital analyst Jeffrey Silber has maintained a Market Perform rating on CoStar Group (CSGP) but lowered the price target from $84 to $79.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 3:48 pm

RIVN

Rivian Automotive Inc (NASDAQ:RIVN) shares dropped significantly in premarket trading after reporting lower-than-expected Q4 earnings. Despite exceeding 2023 production targets, analyst Chris Pierce from Needham has revised his forecast for Rivian due to uncertainties around 2024 R1 production and demand concerns. Pierce maintained a Buy rating but lowered the price target from $22 to $18, citing increased demand concerns and the complexity of the R1 line shutdown and re-ramp as overhangs.

Portfolio Pulse from Priya Nigam

February 22, 2024 | 3:47 pm

MFC

Jefferies analyst John Aiken initiates coverage on Manulife Financial with a Buy rating and a price target of C$40.

Portfolio Pulse from Benzinga Newsdesk

February 22, 2024 | 3:43 pm

ETSY

Etsy Inc (NASDAQ:ETSY) shares fell after Q4 results, despite beating sales and earnings expectations, due to a subdued outlook and soft January performance. Analysts from Wedbush, Needham, Oppenheimer, and KeyBanc Capital Markets provided mixed reviews, focusing on buyer growth, fee expansion, and competitive challenges. Price targets ranged from $80 to $95, with ratings from Neutral to Buy.

Portfolio Pulse from Priya Nigam

February 22, 2024 | 3:31 pm